Articles > Reference > Dictionaries, Thesauruses, Pictures, and Press Releases > M2 Presswire press releases > April-June 2009 > Friday, May 8

Article: Addex Pharmaceuticals - Financial and Strategic Analysis Review.

Article from:
M2 Presswire
Article date:
May 8, 2009
Copyright

M2 PRESSWIRE-8 May 2009-Research and Markets: Addex Pharmaceuticals - Financial and Strategic Analysis Review(C)1994-2009 M2 COMMUNICATIONS LTD

RDATE:08052009

Dublin - Research and Markets (http://www.researchandmarkets.com/research/96addf/addex_pharmaceutic) has announced the addition of Global Markets Direct's new companyprofile "Addex Pharmaceuticals - Financial and Strategic Analysis Review" to their offering.

Addex Pharmaceuticals - Financial and Strategic Analysis Review

Summary

Addex Pharmaceuticals is a company engaged in discovery based development of allosteric modulators, small molecule therapeutic agents that ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Addex Pharmaceuticals - Financial and ...
M2 Presswire;  May 3, 2009 ;     700+ words ... ... companiesandmarkets.com: Addex Pharmaceuticals - Financial and Strategic Analysis Review(C)1994 ... com adds new report: Addex Pharmaceuticals - Financial and Strategic Analysis Review Addex Pharmaceuticals - Financial and Strategic ...

Article: Addex Pharmaceuticals Appoints Head of ADME/PK
CCNMatthews Newswire;  August 17, 2007 ;     598 words ... ... August 16, 2007) - Allosteric modulation company Addex Pharmaceuticals Ltd announced today that Bruno Bournique has been appointed ... team," said Vincent Mutel, CEO of Addex. About Us Addex Pharmaceuticals Ltd discovers and develops allosteric modulators, an ...

Article: Addex Pharmaceuticals First Half 2007 Financial ...
CCNMatthews Newswire;  July 25, 2007 ;     700+ words ... ... 1141649/ 215819.pdf Allosteric modulation company Addex Pharmaceuticals Ltd. (SWX: ADXN) reported today its financial results ... CHF3-4 million." Conference call & webcast Title: Addex Pharmaceuticals First Half 2007 Financial Results Conference Call Date ...

Article: Corrected Version: Addex Pharmaceuticals First Half ...
CCNMatthews Newswire;  July 25, 2007 ;     700+ words ... ... 1141707/ 215862.pdf Allosteric modulation company Addex Pharmaceuticals Ltd. (SWX: ADXN) reported today its financial results ... CHF3-4 million." Conference call & webcast Title: Addex Pharmaceuticals First Half 2007 Financial Results Conference Call Date ...

Article: Addex Pharmaceuticals SA.(Other News To Note)
BioWorld International;  April 25, 2007 ;     461 words ...Addex Pharmaceuticals SA, of Geneva, said it successfully completed a Phase IIa proof-of-concept trial with its lead compound, ADX10059, in patients ...

Article: Addex Pharmaceuticals R&D Day on April 24 ; ...
CCNMatthews Newswire;  March 28, 2008 ;     700+ words ...GENEVA, SWITZERLAND--(Marketwire - March 28, 2008) - Addex Pharmaceuticals (SWX: ADXN) invites investors, analysts and media to attend its first R&D day on Thursday, April 24, 2008 in Geneva, Switzerland ...

Article: Addex Pharmaceuticals 2007 Financial Results
CCNMatthews Newswire;  February 26, 2008 ;     700+ words ... ... hugin.info/138017/R/ 1195007/242282.pdf Geneva, Switzerland - Allosteric modulation company Addex Pharmaceuticals (SWX: ADXN) released today 2007 financial results and reiterated the status of its pipeline. Financial Highlights ...

Article: Swiss allosteric modulation company Addex ...
Chemistry and Industry;  February 25, 2008 ;     655 words ...Swiss allosteric modulation company Addex Pharmaceuticals has signed a second collaboration within a month with US pharma major Merck & Co, in this case, for the development of ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives